Company: XTIA
Filing Date: 2025-03-31
Form Type: 424B5
Source: 0001013762-25-004458
Chunk: 20

Company: XTI Aerospace, Inc.
Filing Date: 2025-03-31
Form: 424B5
Chunk 20
---
. Accordingly, our stock would be less liquid than it would be otherwise.
Also, the prices of OTC stocks are often more volatile than Exchange-listed stocks. Additionally, institutional investors are usually
prohibited from investing in OTC stocks, and it might be more challenging to raise capital when needed.

Sales of a substantial number of our shares of common stock in the public markets, or the perception that such sales could occur, could cause our stock price to fall.

We may issue and sell additional
shares of common stock in the public markets, including during this offering. As a result, a substantial number of our shares of common
stock may be sold in the public market. Sales of a substantial number of our shares of common stock in the public markets, including in
connection with this offering, or the perception that such sales could occur, could depress the market price of our common stock and impair
our ability to raise capital through the sale of additional equity securities.

Our stock price is volatile, and your investment may suffer a decline in value.

The closing market price for our common stock has varied between a
high of $1,147.50 on April 3, 2024, and a low of $2.38 on March 21, 2025, in the twelve-month period ended March 26, 2025. During this
time, the price per share of common stock has ranged from an intra-day low of $2.30 per share to an intra-day high of $1,270 per share.
As a result of fluctuations in the price of our common stock, you may be unable to sell your shares at or above the price you paid for
them. The market price of our common stock is likely to continue to be volatile and subject to significant price and volume fluctuations
in response to market, industry and other factors, including the risk factors described under the section captioned “Risk Factors”
contained in our Annual Report on Form 10-K for the year ended December 31, 2023, and our Quarterly Reports on Form 10-Q for the quarterly
periods ended March 31, 2024, June 30, 2024 and September 30, 2024, all of which are incorporated by reference in this prospectus supplement
in their entirety. The market price of our common stock may also be dependent upon the valuations and recommendations of the analysts
who may in the future cover our business. If the results of our business do not meet these analysts’ forecasts